Chile Molecular Diagnostic Analyzers and Reagents, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

May 2019 | 1120 pages | ID: CD68CB81707EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

• Five-year test volume and sales forecasts
• Feature comparison of major analyzers
• Profiles of market players and start-up firms developing innovative technologies and products
• Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

• Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
• Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

• Comparison of leading molecular diagnostic analyzers.
• Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
  • PCR
  • bDNA
  • SDA
  • NASBA
  • SSSR, and others
  • LCR
• Companies, universities and research centers developing new molecular-diagnostic technologies and products.

Competitive Assessments

Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations

• New product development opportunities with potentially significant market appeal during the next five years.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VI. MOLECULAR DIAGNOSTIC TECHNOLOGY REVIEW

A. DNA Sequencing
B. DNA and RNA Probe Technologies
C. Detection Technologies
D. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
E. Pharmacogenomics
F. Competing/complementing
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two-Dimensional Electrophoresis
  4. Flow Cytometry

VII. MOLECULAR DIAGNOSTIC INSTRUMENTATION REVIEW

VIII. MAJOR APPLICATIONS

  1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
      AIDS/HIV
      Adenovirus
      Aeromonads
      Anthrax/Bacillus Anthracis
      Arboviruses
      Babesiosis
      Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
      Blastocystis Hominis
      Brucella
      Campylobacter
      Candida
      Chagas Disease
      Chancroid
      Chlamydia
      Clostridium Difficile
      Coronaviruses
      Coxsackieviruses
      Creutzfeldt-Jakob’s Disease
      Cryptosporidium Parvum
      Cyclospora Cayetanensis
      Cytomegalovirus
      Ebola Virus
      E. Coli
      Echovirus
      Encephalitis
      Enteroviruses
      Epstein-Barr Virus
      Giardia Lamblia
      Gonorrhea
      Granuloma Inguinale
      Hantavirus
      Helicobacter Pylori
      Hepatitis
      Herpes Simplex Virus
      Human Herpes Virus-6 (HHV-6)
      Influenza Viruses
      Legionella
      Lyme Disease
      Lymphogranuloma Venereum (LGV)
      Malaria
      Measles (Rubeola)
      Meningitis
      Microsporidium
      Mononucleosis
      Mumps
      Mycoplasma
      Papillomaviruses
      Parvovirus B19
      Pneumonia
      Polyomaviruses
      Pseudomonas Aeruginosa
      Rabies
      Respiratory Syncytial Virus (RSV)
      Rhinoviruses
      Rotavirus
      Rubella
      Salmonellosis
      Septicemia
      Shigellosis
      Staphylococcus Aureus
      Streptococci
      Syphilis
      Toxoplasmosis
      Trichomonas Vaginalis
      Tuberculosis
      Vibrio
      West Nile Virus
      Yersinia
  2. Cancer Testing
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
      Abl/abl-bcr
      AIB1
      BCL-2
      BRCA1
      CD44
      C-fos
      C-myb
      C-myc
      CYP17
      Erb-B
      HPC1
      N-myc
      P40
      P51
      P53
      PIK3CA
      PTI-1
      Ras
      Reg
      Sis
      Src
  3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      Maternal-Fetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. DNA Profile Data Banks
    d. Judicial Implementation
    e. Major Crime Categories
    f. Factors Contributing to the DNA Probe Market Expansion
      Technology Availability
      Use of Hair as Evidence
    g. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other

IX. MARKET SIZE AND GROWTH: TEST VOLUME AND SALES FORECASTS

X. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher/Affymetrix

XI. APPENDIX: RESEARCH CENTERS DEVELOPING NEW TECHNOLOGIES AND PRODUCTS

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume and Sales Forecasts by Major Application
Molecular Diagnostics Test Volume by Major Application
Major Infectious Disease Test Volume by Assay
Major Infectious Disease Test Volume by Method
Molecular Diagnostics Market by Major Application
Major Infectious Disease Diagnostics Market by Assay
Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases